Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metoclopramide as Treatment of Clozapine-induced Hypersalivation

NCT02222220 is registered in ClinicalTrials.gov with Beersheva Mental Health Center as lead sponsor.

NCT NCT02222220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02222220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metoclopramide as Treatment of Clozapine-induced Hypersalivation
Lead sponsor
Beersheva Mental Health Center
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2012
Completion date
May 31, 2014
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clozapine-induced hypersalivation